title: Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53.
abstract: Rb protein (pRb) expression was evaluated in 185 cases of transitional cell carcinoma of the bladder from patients that underwent radical cystectomy. Tumors were stratified into three categories based on the percentage of nuclei expressing pRb: (a) 0, 0% of tumor cells showing nuclear reactivity; (b) 1+, 1-50% of tumor cells showing nuclear reactivity; and (c) 2+, >50% of tumor cells showing nuclear reactivity. Cases with undetectable (pRb 0) and high (pRb 2+) pRb reactivity had identical rates of recurrence. These cases had significantly higher recurrence (P = 0.0001) and lower survival rates (P = 0.0002) compared to cases with moderate (pRb 1+) pRb reactivity, indicating that high levels of pRb expression may reflect a dysfunctional (altered) Rb pathway. The tumors were also examined for alterations in p53 expression; patients with tumors altered in both p53 and pRb had significantly increased rates of recurrence (P < 0.0001) and survival (P < 0.0001) compared to patients with no alterations in either p53 or pRb; patients with alterations in only one of these proteins had intermediate rates of recurrence and survival. These results suggest that: (a) bladder cancers with high pRb expression do not show the tumor suppressor effects of the protein; and (b) alteration in both p53 and pRb may act in cooperative or synergistic ways to promote tumor progression.
authors.affiliation: Department of Pathology, University of Southern California School of Medicine/Norris Comprehensive Cancer Center, Los Angeles 90033, USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Cote
authors.forename: M D
authors.initials: MD
authors.lastname: Dunn
authors.forename: S J
authors.initials: SJ
authors.lastname: Chatterjee
authors.forename: J P
authors.initials: JP
authors.lastname: Stein
authors.forename: S R
authors.initials: SR
authors.lastname: Shi
authors.forename: Q C
authors.initials: QC
authors.lastname: Tran
authors.forename: S X
authors.initials: SX
authors.lastname: Hu
authors.forename: H J
authors.initials: HJ
authors.lastname: Xu
authors.forename: S
authors.initials: S
authors.lastname: Groshen
authors.forename: C R
authors.initials: CR
authors.lastname: Taylor
authors.forename: D G
authors.initials: DG
authors.lastname: Skinner
authors.forename: W F
authors.initials: WF
authors.lastname: Benedict
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000235:genetics*; D018572:Disease-Free Survival; D015972:Gene Expression Regulation, Neoplastic; D016161:Genes, Retinoblastoma; D016158:Genes, p53; D006801:Humans; D007150:Immunohistochemistry; D016160:Retinoblastoma Protein / Q000235:genetics*; D016019:Survival Analysis; D001749:Urinary Bladder Neoplasms / Q000235:genetics* / Q000473:pathology*
chemical_list: D016160:Retinoblastoma Protein